Gloucestershire Health and Care- NHS Trust logo
with you, for you
Archive for Health

Search for a reference number

Health

Children’s Continence Service

,

Continence care is a critical component of children’s health and wellbeing. National guidance, including the Children’s Continence Commissioning Guide and the Consensus Document for the Provision of Continence Containment Products to Children and Young People, highlights the importance of accessible, multidisciplinary services that meet assessed clinical need and promote independence.

Under the provisions of the Freedom of Information Act (FOIA), we would be most grateful if you could provide answers to the following questions regarding your Trust’s children’s continence and/or bladder and bowel services. We kindly request responses to the following questions:

1. Does your Trust currently provide a children’s continence and/or bladder and bowel service for individuals aged 0–19 years? (Yes/No) 

If yes, please provide: 
• The name of the service (if applicable). 
• The age range it covers. 
• The staff roles or disciplines included in the service (e.g. nurse, physiotherapist, occupational therapist). 
• The number of staff in each role, expressed as whole-time equivalent (WTE). 
• The service’s referral pathway (e.g. GP, school nurse, self-referral). 

2. Has your Trust closed, reduced, or restructured any part of its children’s continence and/or bladder and bowel service within the past three years (since October 2022)? (Yes/No) 

If yes, please provide: 
• The date of closure or reduction. 
• A brief description of what changed (e.g. staffing, eligibility criteria, service capacity). 

3. How many children and young people aged 0–19 are currently being supported by your adult continence service for pad provision? Please provide the number of individuals currently recorded in this category. 

4. What is the average waiting time (in weeks) for an initial assessment on the children’s continence service? Please provide the current number of children and young people (aged 0–19) on the waiting list for this service. 

5. Does your Trust follow the relevant NICE guidelines for continence care and management? Please indicate Yes or No for each 
• Children’s Continence Commissioning Guide: A handbook for the commissioning and running of children’s community continence services 
• Guidance for the provision of continence containment products to children and young people – A consensus document     

We appreciate your time and assistance in responding to this request and look forward to your reply within the statutory period.

read more

Services Users Currently Open to the Crisis Team

, ,

1. The number of service users currently open to the Gloucester Crisis Resolution and Home Treatment Team (CRHTT) as of 29.10.25.    

2. Of these, how many have a care plan attached to their electronic patient record.    

3. If available, please also provide the percentage this represents. I am not requesting any personal or identifiable data.

4. Also, please can you provide the total number of inpatient beds available for mental health patients across Gloucestershire from 01/01/25 to 30/01/25.

read more

Stroke Patient Clinical Data

,

Dear Freedom of Information Team

Please could I request, under the Freedom of Information Act 2000.

1. The total number of stroke patients in the Trust and the number of stroke patients in the Trust that were:

a) offered a six-month post-stroke review

and

b) had a six-month post-stroke review for each of the past 5 years, beginning with 2020.

I look forward to your reply in the statutory 20 days.

I would appreciate a reference number being provided so I can keep track of the request.

read more

Care Reviews – Crisis Team

,

Please could you provide me with the key learning themes and recommendations identified from care reviews relating to deaths by suicide, where individuals were open to the Crisis Team within Gloucestershire at the time of death.
In addition, could you please provide evidence of how these recommendations have been implemented into policy and practice during the following periods:

• January 2024 – January 2025
• January 2025 – present day

read more

Paediatric Elective Care (RTT)

, ,

Under the Freedom of Information Act 2000 I would like to request the following information.

Please provide two sets of waiting list data on paediatric elective care (RTT) (patients aged 0–17) for your Trust, disaggregated by:

1. Ethnicity (using NHS standard ethnicity categories), and
2. Indices of Multiple Deprivation (IMD) deciles or quintiles (based on patient postcode or other available proxy).

For each combination of ethnicity and IMD group, please provide the number of patients waiting in each of the following time bands:

1. Up to 18 weeks
2. 18 to 26 weeks
3. 26 to 40 weeks
4. 40 to 52 weeks
5. 52 weeks and over

Please provide this data monthly, from September 2021 to September 2025 (or the most recent available month), with each month reported separately.

If providing both ethnicity and IMD breakdowns would exceed the cost, please prioritise the ethnicity breakdown.

Please provide the data in spreadsheet format (e.g., Excel or CSV).

read more

CAAAS Waiting Lists

, ,

Please can you answer the following (I have already FOI’d and I am happy to include this in the next FOI).

1. How are the waiting times for the CAAAS shared within the organisation?

2. What is the governance process from team to Board to ensure the Board is sighted on this issue?

3. I note your Trust risk register as reported in latest board figures is quite generic.

a. Is the CAAAS waiting list issue on the risk register?
b. What is it scored and what are the mitigating actions?

4. There was limited mention of CAAAS in any of your 2025 Board Papers (this links to my point above). There was a quote from a NED at the Go and See in May Board papers ‘the waiting list is impacted by several factors including the amalgamation of others’ waiting lists into CAAAS’.

a. What is the material impact?
b. What is the nature of the problem?
c. How is the service mitigating the impact?

5. How are you assuring yourself around actual or potential harm relating to the extremely extended waits in CAAAS?

6. Further to above if the waiting list is growing what is the organisation doing regarding mutual aid or outsourcing?

read more

Community Mental Health Access

,

This Freedom of Information request question is for your Community Mental Health Teams in your area (i.e. NOT your Early Intervention in Psychosis team; Crisis Resolution or Home treatment team; or Rehabilitation and Recovery team or Assertive Outreach team).

Please can you provide information on the below questions in relation to the following case example.

A 35-year-old person with severe OCD and BDD has been assessed by your local Talking Therapies service as being too complex and inappropriate for them. They are severely impaired, virtually housebound, have no social life and unable to work. Their basic needs are provided by the family, but the family is struggling to support them. They are not an immediate risk of suicide, self-harm or violence to others and do not need admission to an acute ward. They are not personality disordered. The GP has already followed the NICE guidelines for OCD/BDD, and the patient has had 2 trials of SSRIs at maximum dose for at least 4 months each with little benefit. The patient and their family are seeking an assessment by a consultant psychiatrist and cognitive behaviour therapy with exposure and response prevention which is specific for OCD/BDD.

1. How long approximately is the wait list (e.g. number of weeks) to obtain an assessment by the CMHT and would this be by a consultant psychiatrist or their specialist trainee?
2. Are there criteria used to accept a rereferral onto your Community Mental Health Teams to have a care co-ordinator and provide treatment? If you have criteria, please can you supply them?
3. How long approximately is the wait list to obtain (a) a psychological assessment and then (b) how long is wait for CBT for OCD/BDD in secondary care (e.g. number of weeks)?
4. What is the documented or expected care pathway (e.g. do they have to be seen first by the CMHT and then referred by the CMHT for secondary care psychological therapies or can the referral be done directly by the Talking Therapies or GP for example)?
5. Do your policies or procedures indicate that any alternatives offered to CBT with ERP, for people in the above scenario, e.g. a different type of psychological therapy?
6. Has your team made a referral to tertiary services for OCD/BDD in the last 5 years a) under the Highly Specialised Service stream of funding or b) under local funding?

read more

Monitoring Technology used in Patient Bedrooms

, , , ,

Dear Gloucestershire Health and Care NHS Foundation Trust,

I am writing to request the following information under the Freedom of Information Act.

1. Please confirm, does the Trust use, or have plans to use, Oxevision* in ward bedrooms, 136 suites and/or seclusion rooms?

*Please note that Oxevision may be referred to by other names including LIO or ‘vision-based monitoring technology’ etc. It is an infrared camera system.

2. Please confirm, does that Trust use, or have plans to use, ‘Project X’^ in ward bedrooms, 136 suites and/or seclusion rooms.

^Please note that Project X may be referred to by different names, for the avoidance of doubt it is marketed by Safehinge Primera and may be described as a ‘non-visual patient safety aid’ and uses radar to track patients’ movements.

3. Please outline whether the trust uses any other video, camera or vision-based patient monitoring systems within patient bedrooms. Please state brand names if appropriate.

4. If the response to any of the above questions is ‘yes’, please provide the following information:

4.1. Please confirm the number of wards/136 suites/seclusion rooms, and provide ward names, where Oxevision/Project X/other vision based monitoring technologies is currently used.

4.2. Please provide your policy or standard operating procedure for the use of Oxevision/Project X/other vision based monitoring technologies, up to the date and time of this request.

4.3. Please provide your Data Protection Impact assessment for the use of Oxevision/Project X/other vision based monitoring technologies.

4.4. Please provide an Equality Impact Assessment in relation to the use of Oxevision/Project X/other vision based monitoring technologies

4.5. Please state the contract end date(s) for all current contract(s) with Oxehealth/LIO health/other organisations that provide the above technologies..

4.6. Please provide patient posters, leaflets and/or information packs.

read more

Cardiology Software and Vendor Neutral Archive Systems

, ,

Good morning,
I am writing to request information under the Freedom of Information Act 2000.

Please could you provide the following details regarding your Trust’s use of digital systems in the cardiology department:

1. Does your Trust currently use any software systems to manage clinical records, diagnostics, or workflows within cardiology?

2. If yes, please provide:

a The name of the software provider and product.
b The start date and duration of the current contract.
c The expiry date or next renewal date of the contract.
d Whether the contract includes options for extension or renewal.

Additionally:

3. Does your Trust currently use a Vendor Neutral Archive (VNA) system to store and manage medical imaging or other clinical data across departments?

4. If yes, please provide:

a The name of the VNA provider and product.
b The departments where it is currently deployed.
c The start date, duration, and expiry/renewal date of the contract.
d Whether the contract includes options for extension or renewal.

I would prefer to receive the information electronically, if possible. I understand that under the Act, you are required to respond to this request within 20 working days. If any of the requested information is exempt from disclosure, please specify the exemption and provide any non-exempt information that can be released.

Thank you for your assistance.

read more

Designing safe spaces for patients at high risk of infection

To: Infection Control Teams Dear Colleagues,

We are carrying out a short 10 question survey to understand how NHS Trusts are implementing the guidance from NHS Estates Technical Bulletin 2024/3: Designing safe spaces for patients at high risk of infection from nontuberculous mycobacteria (NTM) and other waterborne pathogens.

This survey is being carried out to gain insight into how the recommendations of the bulletin have informed local water safety practice and capital planning across NHS organisations; and to identify common challenges in water safety management across healthcare settings.

A summary of anonymised findings will be shared with participating Trusts on request.

Under the Freedom of Information Act 2000, we seek the following information within your NHS Trust / NHS Foundation Trust:

1. Name of NHS Trust/Foundation Trust:

2. Has your organisation reviewed NHS Estates Technical Bulletin 2024/3 with the specific note on non-tuberculous mycobacteria?

Yes
No

3. Does your organisation treat any of the “high-risk” patient groups listed in the NHS Estates Technical Bulletin 2024/3? Tick all that apply

Lung and/or heart transplant
Cystic fibrosis
Haematology/oncology patients with neutropenia,
CAR-T cell patients
Other solid organ transplant,
Patients with long-term lines

4. Do you have a Water Safety Group or equivalent multidisciplinary body for any water-related issues?

Yes
No

5. Do you currently conduct routine environmental water testing for NTM? If yes, please state the areas tested and the frequency of testing.

Yes
No

Areas tested (type here):

Frequency (type here):

6. Does your Water Safety Plan include specific controls for NTM, separate from general Legionella/Pseudomonas measures? – If yes, please specify.

Yes
No

Specify (Type here):

7. If NTM testing is undertaken, which laboratory/method is used, and is it UKAS-accredited to ISO 17025 for NTM testing or according to the methods suggested in the bulletin?

N/A (have not tested for NTM)

If testing, which laboratory/method is used? (type here):

Is testing method accredited (type here):

8. If you have tested, have you detected NTM in water samples from patient care areas in the last 3 years? (Yes/No; if yes, please indicate the area(s) and summarise the control measures taken).

Yes
No

N/A (have not tested for NTM)

Specify areas (type here):

Summarise control measures (type here):

9. Which control and/or remedial measures are you currently using to manage waterborne pathogens in your organisation? Tick all that apply

Point-of-use filters
Temperature controls
Chemical controls (any, i.e. chlorine, silver-copper ionization)
Pipe removal work (including new copper pipes)
Descaling and cleaning of water outlets
Complete removal of outlets/sink
Other (please list below)

Other (type here):

10. In the last 5 years, have you made any design changes in high-risk areas specifically to reduce waterborne infection risk (e.g., removal or relocation of sinks, drainage modifications, point-of-entry filtration)? (Yes/No; please provide brief examples).

Yes
No

11. Are you planning any major refurbishment in the next 5 years and/or is your organization part of the NHS New Hospital Programme? (Tick all that apply)

Yes – planning refurbishment works
Yes – part of the NHS New Hospital Programme
No – neither

read more

Electroconvulsive Therapy (ECT) 2024

,

Good evening,

This is a request under the Freedom of Information Act 2000.

Please provide the following information relating to your Trust’s use of electro-convulsive therapy for the period between 1 January 2024, to 31 December 2024:

Treatments delivered by consent status, specifically including the number of treatments given to a) those incapable of consenting, but ECT authorised where patient resists or objects (under Mental Health Act Section 58A), and b) those incapable of consenting, but ECT authorised where a patient does not resist or object (under Mental Health Act Section 58A).

If information with this distinction is unavailable, please simply provide it for the number of treatments where a patient did not consent.

Please confirm the number of patients this pertains to for this period.

Please also separate this information out by age, gender, and IMD decile (or if not possible, quintile).

read more

Patient Notes — Paper and Electronic

,

I would like to request the following information under the Freedom of Information Act.

Question 1:
– Are PATIENT NOTES* in your trust: all paper, all electronic, or a mixture of both?
– If patient notes are primarily electronic:
– When did the trust transition from paper to electronic?
– What is the name of the electronic patient record platform used?
– If patient notes are primarily paper:
– Are there plans to transition from paper to electronic? If yes, when?
* ‘Patient notes’ here refers to written documentation of clinical encounters with patients, completed by a healthcare professional.

Question 2:
– Are DRUG CHARTS in your trust all paper, all electronic, or a mixture of both?
– If drug charts are primarily electronic:
– When did the trust transition from paper to electronic?
– What is the name of the electronic prescribing system used?
– If drug charts are primarily paper:
– Are there plans to transition from paper to electronic? If yes, when?

Question 3:
– Do the following departments in your trust use paper PATIENT NOTES (either partially or fully)? Please indicate Yes, No or Not sure / Not applicable.
– Inpatient wards
– Outpatients

Question 4:
– Do the following departments in your trust use paper DRUG CHARTS (either partially or fully)? Please indicate Yes, No or Not sure / Not applicable.
– Inpatient wards
– Outpatients

Question 5:
– Are fax machines still used in any part of your trust? (Yes / No)

If you have any queries, please don’t hesitate to contact me on ssantospaulo@bmj.com

read more

Wound Care

I have attached a word document which has been laid out for ease. It clearly identifies what information I would like to receive from this freedom of information request.
By saving the attached word document file, it will allow you to fill in the boxes directly, alternatively, it can be printed off and filled in manually if that is easier.

read more

Spiritual, religious and/or chaplaincy services

,

As part of a piece of work I am undertaking to review the spiritual, religious, and / or chaplaincy services offered by NHS England, I am contacting you to ask for the following information to please be provided.

1. How many whole-time equivalents are employed in the spiritual, religious, and / or chaplaincy service(s) and what are their bandings? Please differentiate between staff on substantive and temporary contracts, as well as staff working in the service on bank or agency contracts.

2. What are the typical core hours of the spiritual, religious, and / or chaplaincy service(s) on offer? How are these service(s) provided over the week (i.e. weekdays only, seven days a week, etc)?

3. What type of support (such as regular activities, events, or gatherings) is offered by the spiritual, religious, and / or chaplaincy service(s)? Please differentiate this between support offered to patients, support offered to family / friends, and support offered to staff members.

4. What on-call or out-of-hours provisions are made by the spiritual, religious, and / or chaplaincy service(s) at your Trust? Please differentiate between provisions offered by staff members employed by the Trust, and provisions offered by external contractors / arrangements.

5. What support is offered to the spiritual, religious, and / or chaplaincy services(s) by external organisations? For instance, what contracts are held by the Trust for this / these service(s) and who are these contracts with?

6. On average, how many service users are supported by the spiritual, religious, and / or chaplaincy service(s) in a week? Please take an average of service users supported between January and December 2024.

7. What is the overall satisfaction for the spiritual, religious, and / or chaplaincy service(s) offered by your Trust? Please provide the overall satisfaction for the period January 2024 to December 2024.

8. What supervision, if any, is provided to staff working in the spiritual, religious, and / or chaplaincy service(s)? Please identify whether this is provided by your Trust or by an external provider, and the average annual cost for this provision.

9. Please provide a contact name and contact email address if there should be any additional queries relating to this Freedom of Information request.

read more

Insourcing for Pathology Services

Under the Freedom of Information Act 2000, I request the following information regarding your use of insourcing for haematology, histopathology, and/or microbiology services between 1 April 2024 and the date of this request (i.e., the last 12 months):

Service Usage:

Does your trust currently use (or has it used in the last 12 months) insourcing providers for any of the following services?

a) Haematology
b) Histopathology
c) Microbiology
d) Oncology
(If yes, please specify which specialties)

Provider Details:

For each insourced specialty above, provide:
a) The name(s) of the external provider(s).
b) The start and end date(s) of the contract(s).

Scope & Volume:

A brief description of the services covered (e.g., “blood film reporting,” “biopsy analysis,” “infection screening”).

Estimated annual spend (or total spend) on these insourcing arrangements for 2023/24.

Procurement Method:
Was the contract awarded via a framework (e.g., NHS SBS DPS, Crown Commercial Service)? If yes, state which one.

If no insourcing is used for these specialties, please state “None.”

read more

Exceptions for Routine Treatment Implants

I understand that whilst the Sexual Health team do not provide routine treatment regarding certain implants, exceptions may be made for certain groups. Please could you share a copy of the exceptions list / exceptions policy?

read more

Wheelchair Services: Open Caseloads and Waiting Times

As you will be aware, the recently released Wheelchair Alliance report has highlighted the postcode lottery experienced by wheelchair users, and the many long waits. I am interested in the underlying data.

Please provide the following information separately for each of the wheelchair services in your area. This data is ‘essential’ or ‘basic’ information relating to each referral and should be easily extracted from the relevant Case Management System, Electronic Patient Record, or similar. Please feel free to provide the data in alternative formats, e.g. an Excel spreadsheet, if appropriate.

1a) How many open referrals does the service have for ADULTS?
1b) Of those open referrals, how many have been open for LESS than 18 weeks?
1c) Of those open referrals, how many have open for MORE than 18 weeks?
1d) Of those open referrals, how many have been open for MORE than 52 weeks?
1e) Of those open referrals, how many are ‘low need’ (per NHS Wheelchair Data Collection definition)?
1f) Of those open referrals, how many are ‘medium need’?
1g) Of those open referrals, how many are ‘high need’?
1h) Of those open referrals, how many are ‘specialist need’?
1i) Of those open referrals, how many are for powered wheelchairs?

2a) How many open referrals does the service have for CHILDREN/YOUNG PEOPLE?
2b) Of those open referrals, how many have been open for LESS than 18 weeks?
2c) Of those open referrals, how many have open for MORE than 18 weeks?
2d) Of those open referrals, how many have been open for MORE than 52 weeks?
2e) Of those open referrals, how many are ‘low need’ (per NHS Wheelchair Data Collection definition)?
2f) Of those open referrals, how many are ‘medium need’?
2g) Of those open referrals, how many are ‘high need’?
2h) Of those open referrals, how many are ‘specialist need’?
2i) Of those open referrals, how many are for powered wheelchairs?

read more

Administering of Injections

,

I am writing to request information under the Freedom of Information Act 2000 regarding the administration of injections to patients without their consent within the Trust.

Specifically, I request the following information for the period 1 January 2020 – 15 March 2025:
1. The total number of times patients were administered injections without their consent and the date of any such cases.
2. A breakdown of the medications administered (e.g., antipsychotics, sedatives) in these cases.
3. The legal authority under which these injections were administered.
4. The number of incidents where rapid tranquilization was used and the date of any such cases.
5. Any policy documents or guidelines used by the Trust regarding the administration of injections without consent.

If any part of this request exceeds the cost limit under the FOI Act, I would appreciate advice on how I may refine my request to stay within the limit.

read more

Use of Processed Meats Containing Nitrates or Nitrites in Meals

I am writing to make a request for information under the Freedom of Information Act 2000.

I would like to request the following information regarding the use of processed meats containing nitrates or nitrites in meals provided by your authority.

1. Does your organisation procure or serve processed meat (such as bacon, ham, sausages, or other cured meats) that contain nitrates or nitrites as preservatives?

2. If so, please provide details of the types of processed meat served and any guidance or policies in place regarding their procurement.

read more

NHS Treatment of Botched Overseas Surgeries

I am submitting this request under the Freedom of Information Act 2000 to obtain data on NHS treatment of complications arising from surgical procedures performed overseas.

Request Details

1. NHS Admissions for Complications Following Overseas Surgeries
• The total number of hospital admissions where the NHS has treated patients for complications resulting from surgeries conducted abroad.
• A yearly breakdown from January 2020 to January 2025 (or the most recent available period).

2. Breakdown of Patients Treated
For each year, please provide where available:
• Age group of patients (e.g.: under 18, 18-24, 25-34, 35-44, 45-54, 55-64, 65+).
• Gender of patients.

3. Data Classified Under Relevant ICD-10 Codes (or their NHS equivalents):
Please provide a breakdown of cases recorded under the following ICD-10 codes related to complications of surgical procedures:
• T81 – Complications of procedures (e.g., infections, wound disruption, foreign bodies left in the body).
• T82-T85 – Complications of prosthetic devices, implants, and grafts.
• T86 – Failure and rejection of transplanted organs and tissues.
• T87 – Complications of amputations and reattachments.
• T88 – Other complications of surgical and medical care (including anaesthesia-related complications).
• Y60-Y69 – Surgical errors and misadventures (e.g., accidental punctures, foreign objects left inside patients, failure of sterile precautions, inappropriate procedures).
• Y70-Y79 – Medical devices associated with adverse incidents.
• Y83-Y84 – Abnormal patient reactions or complications following surgery or other medical procedures.

4. Specific Details on Procedures Leading to NHS Admissions
Where available, please provide:
• The type of surgery the patient originally underwent abroad (e.g., cosmetic surgery, weight loss surgery, orthopaedic surgery, dental work, etc.).
• The intended purpose of the surgery (e.g., aesthetic enhancement, weight loss, joint replacement, reconstructive surgery, etc.).
• The type of complication requiring NHS intervention (e.g., infection, implant failure, excessive bleeding, wound breakdown, nerve damage, sepsis).

5. NHS Cost of Treating Complications from Overseas Surgeries
• The total annual cost incurred by the NHS in treating complications from overseas surgeries.
• If available, an estimated breakdown of costs by procedure type.

read more

High Acuity Monitoring

We would like to place a Freedom of Information request, wishing to obtain an Install Base report for Monitoring systems within high acuity areas at your NHS hospitals.

Additional Questions

• How many anaesthetic rooms do you have in Theatres?
• How many theatre rooms do you have?
• Do you have a telemetry system for coronary care?
• How many telemetry systems do you have?

read more

Analysis on the Uptake of Biosimilar Use for Ustekinumab

I am conducting an analysis on the uptake of biosimilar use for Ustekinumab.

I would be grateful if you could please tell me how many patients were treated with Ustekinumab (for any disease) for the three-month period specified within the questions.

Q1 – How many patients were treated with Ustekinumab and its biosimilars (for any disease) from the start of October 2024 to the end of December 2024?
Please use the latest available 3 months if October to December is not available and specify which 3 months have been used.

Q2 – How many patients were treated with Stelara and its biosimilars (for any disease) in the months October 2024, November 2024, and December 2024?
Please use the latest available 3 months if October to December is not available and specify which 3 months have been used.

read more

Ophthalmology IT Systems and Imaging Capabilities

,

Under the Freedom of Information Act 2000, I would like to request the following information regarding the ophthalmology services and IT systems used within your Trust:

Ophthalmology Department & IT Record System
1. Does your Trust have an ophthalmology department and/or provide ophthalmology clinics?
2. If so, what is the name of the principal IT record system used to document results from patient consultations within ophthalmology?

Imaging Capabilities & System Integration
3. Does the principal IT system allow clinicians to view images from scans conducted during a clinic visit?
4. Are there any types of medical images that cannot be imported into this principal IT system? If so:
• What is the name of the IT programme used by clinicians to view these images?
• What is the name of the scan/modality that generates these images?

Data Integration with National Systems
5. Does the principal IT system integrate with the NHS Spine or other national patient record systems (e.g., OpenEyes, Medisoft, Epic)?
6. Does the system support the exchange of structured data with other NHS Trusts or external healthcare providers?

Patient Access & Communication
7. Does the system allow patients to access their ophthalmology records, including images, via the NHS App or another patient portal?
8. Are there any restrictions on how imaging data can be shared with patients and external providers?

Image Storage & Viewing Capabilities
9. What is the storage capacity and retention policy for ophthalmology-related imaging within the IT system?
10. If images are not viewable within the principal IT system, does the Trust use a separate PACS (Picture Archiving and Communication System) for ophthalmology imaging?

Future IT Developments & Interoperability
11. Is the Trust planning any upgrades or changes to its ophthalmology IT infrastructure in the next five years?
12. Are there known interoperability challenges that affect the transfer of ophthalmology data within the Trust or between NHS organizations?

read more

The Primary Care-Associated Helicobacter Pylori testing

This FOI request seeks to establish the types, numbers, costs and timings of Helicobacter pylori tests performed by your Trust (or on its behalf) for primary care providers.

Question 1: Your Trust
In your response to this FOI request, could you please specify the identity of the parts of your Trust for which this FOI is relevant, and for which you are responding.

Question 2: Types of Tests and Providers Which types of tests relevant for the primary care diagnosis of Helicobacter pylori (e.g., stool antigen test, urea breath test, serology) do you perform within your Trust, or have performed on your behalf by a Third party? If outsourced, could you please specify the Third party used.

Question 3: Test Types and Volumes
How many Helicobacter pylori tests of each of these types were performed by your Trust or on its behalf in the most recent 12-month period, or other defined accounting period for which data is available?

Question 4: Requirements for in-Person Testing Which types of tests required the in-person attendance of the patient at your Trust or its Third-party provider for testing, how many such in-person attendances were required, and what was the average time taken between patient arrival and departure?

Question 5: Turnaround Time for Test Results Specifying each type of Helicobacter pylori test performed by your Trust, or on its behalf, could you please provide the average time (in hours) between receipt of sample to transmission of test result to the GP practice?

Question 6: Test costs and Tariffs
For each type of Helicobacter pylori test performed by your Trust or on its behalf, what is the total cost of performing the test to your Trust or the Third party provider (i.e., personnel, infrastructure, reagents and consumables, etc)? What does your Trust charge for performing each of these tests? Do these tests correspond to standard NHS tariffs or HRG codes? If so, could you please specify the tariff code and amount charged for each test type.

read more